tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Esperion (ESPR)
NASDAQ:ESPR
US Market
ESPR
Esperion
RESEARCH TOOLSreports

Esperion (ESPR) Stock News & Sentiment

Compare
1,647 Followers
Esperion (ESPR): Growing Global Guideline Endorsements and Regulatory Milestones for Bempedoic Acid Support Buy Rating and $16 Target
Premium
Ratings
Esperion (ESPR): Growing Global Guideline Endorsements and Regulatory Milestones for Bempedoic Acid Support Buy Rating and $16 Target
29d ago
ESPR
Esperion’s Global Expansion and Strategic Advancements Drive Buy Rating
Premium
Ratings
Esperion’s Global Expansion and Strategic Advancements Drive Buy Rating
2M ago
ESPR
Esperion’s Market Challenges: Sell Rating Due to Limited Impact of Bempedoic Acid and Mixed Feedback on Combination Strategy
Premium
Ratings
Esperion’s Market Challenges: Sell Rating Due to Limited Impact of Bempedoic Acid and Mixed Feedback on Combination Strategy
2M ago
ESPR
Promising Clinical Data and Strong Market Presence Drive Buy Rating for Esperion
Premium
Ratings
Promising Clinical Data and Strong Market Presence Drive Buy Rating for Esperion
2M ago
ESPR
Esperion Therapeutics Reports Strong Q3 Revenue Growth
Premium
Company Announcements
Esperion Therapeutics Reports Strong Q3 Revenue Growth
2M ago
ESPR
Esperion Therapeutics Reports Strong Q3 Growth Amid Challenges
Premium
Company Announcements
Esperion Therapeutics Reports Strong Q3 Growth Amid Challenges
2M ago
ESPR
Esperion’s Strong Financial Performance and Growth Potential Justifies Buy Rating
Premium
Ratings
Esperion’s Strong Financial Performance and Growth Potential Justifies Buy Rating
2M ago
ESPR
More ESPR News >

ESPR News on the Web

Why Esperion Therapeutics, Inc.’s (ESPR) Stock Is Down 14.79%
AAII
Neutral
Esperion Projects FY2025 U.S. Net Product Sales Growth Of 35% To 38%; Stock Up
rttnews
Bullish
Why Esperion Therapeutics, Inc.’s (ESPR) Stock Is Up 5.21%
AAII
Neutral
ACC Endorsement Positions Esperion’s Bempedoic Acid as Key Therapy for PAD Patients with Diabetes
Market Chameleon
Neutral
ACC Endorsement Positions Esperion’s Bempedoic Acid as Key Therapy for PAD Patients with Diabetes
Market Chameleon
Neutral
Why Esperion Therapeutics, Inc.’s (ESPR) Stock Is Down 5.24%
AAII
Neutral
Why Esperion Therapeutics, Inc.’s (ESPR) Stock Is Up 5.28%
AAII
Neutral
Why Esperion Therapeutics, Inc.’s (ESPR) Stock Is Up 12.31%
AAII
Neutral

News Score - Last 7 Days

Neutral
ESPR
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESPR’s Media Buzz Sentiment?
2 articles about ESPR were published this week. In an average week, 1.25 articles are published.
    What is ESPR’s weekly average amount of articles?
    In an average week, 1.25 articles about ESPR are published.
      What is ESPR’s News Sentiment?
      100% of articles about ESPR were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        CAHCardinal Health
        ALKSAlkermes
        WSTWest Pharmaceutical Services
        AGENAgenus
        PENPenumbra
        Showing the stocks with the most bullish news sentiment over the past week